Jiangsu Hengrui Medicine
600276.SS
$6.19
Share price
2.72%
Change (1 day)
-11.70%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
P/S ratio for Jiangsu Hengrui Medicine (600276.SS)
P/S ratio as of April 2024 (TTM): 12.1
According to Jiangsu Hengrui Medicine 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.1334. At the end of 2023 the company had a P/S ratio of 12.4.
P/S ratio history for Jiangsu Hengrui Medicine from 2003 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 12.4 | 10.48% |
| 2022 | 11.2 | -11.97% |
| 2021 | 12.7 | -43.33% |
| 2020 | 22.4 | 35.94% |
| 2019 | 16.5 | 52.47% |
| 2018 | 10.8 | -24.79% |
| 2017 | 14.4 | 55.63% |
| 2016 | 9.25 | -7.92% |
| 2015 | 10.0 | 32.97% |
| 2014 | 7.55 | -10.35% |
| 2013 | 8.43 | 21.96% |
| 2012 | 6.91 | -6.57% |
| 2011 | 7.40 | -38.95% |
| 2010 | 12.1 | 12.7% |
| 2009 | 10.7 | 27.97% |
| 2008 | 8.40 | -34.51% |
| 2007 | 12.8 | 68.68% |
| 2006 | 7.60 | 135.45% |
| 2005 | 3.23 | 11.58% |
| 2004 | 2.89 | 42.01% |
| 2003 | 2.04 |